European Monitoring Centre for Drugs and Drug Addiction. (2008) GHB and its precursor GBL: an emerging trend case study. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.
Preview | Title | Contact |
---|---|---|
|
PDF (EMCDDA Thematic Paper on GHB)
- Published Version
3MB |
Concerns are increasing in the EU about the use of chemicals employed in the manufacture of the recreational drug GHB. The report GHB and its precursor GBL: an emerging trend case study is published as part of the EMCDDA's E-POD project to track new patterns of drug use in Europe.
Table of contents
• About the E-POD project
• Introduction
• Description
• Prevalence and use patterns
• Markets and availability
• Dose and effects
• Negative health consequences
• Conclusions
B Substances > New (novel) psychoactive substances > GHB / GBL (Gamma hydroxybutyric / Gamma butyrolactone)
J Health care, prevention, harm reduction and treatment > Identification and screening > Identification and screening for substance use
VA Geographic area > Europe > European Union
Repository Staff Only: item control page